stockrowDENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.
- Revenue
- −7.52%
- EPS
- +99.5%
- Free cash flow
- −18.0%
- Total debt
- −1.59%
Quarter to September 2026, against a year earlier
Follow XRAY
Alert me
DENTSPLY SIRONA Inc. (XRAY) Net income
DENTSPLY SIRONA Inc.'s net income for fiscal 2025 was −$598.0M, compared with −$910.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$122.0M. Over the past ten years it has ranged from −$1.6B (fiscal 2017) to $431.4M (fiscal 2016); the current reading is higher than 45% of that period. DENTSPLY SIRONA Inc. ranks 46th of 51 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$598.0M | — |
| FY2024 | −$910.0M | — |
| FY2023 | −$132.0M | — |
| FY2022 | −$950.0M | — |
| FY2021 | $411.0M | — |
| FY2020 | −$73.0M | — |
| FY2019 | $256.0M | — |
| FY2018 | −$1.0B | — |
| FY2017 | −$1.6B | — |
| FY2016 | $431.4M | 71.80% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | −$3.0M | — |
| Jun 2026 | $36.0M | — |
| Mar 2026 | −$10.0M | — |
| Dec 2025 | −$145.0M | — |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| STVN Stevanato Group S.p.A. compare | $227.4M |
| LMAT LeMaitre Vascular, Inc. compare | $63.3M |
| ATRC AtriCure, Inc. compare | $14.9M |
| WRBY Warby Parker Inc. compare | $7.5M |
| STAA STAAR Surgical Company compare | $530.0K |
| PLSE Pulse Biosciences, Inc compare | −$83.8M |
| XRAY DENTSPLY SIRONA Inc. | −$122.0M |
| AZTA Azenta, Inc. compare | −$122.9M |
| KMTS Kestra Medical Technologies, Ltd. compare | −$149.9M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on XRAY
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement